Related Experiment Video
Updated: Nov 22, 2025

Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth
Published on: January 7, 2022
Mechanistic Insight into Royal Protein Inhibiting the Gram-Positive Bacteria
Mao Feng1, Yu Fang1, Chuan Ma1
1Institute of Apicultural Research/Key Laboratory of Pollinating Insect Biology, Ministry of Agriculture and Rural Affairs, Chinese Academy of Agricultural Sciences, Beijing 100093, China.
Abstract:
Royal jelly (RJ), a natural honeybee product, has a wide range of antibacterial activities. N-glycosylated major royal jelly protein 2 (N-MRJP2), purified from RJ, can inhibit the growth of Paenibacillus larvae (P. larvae, Gram-positive), a contagious etiological agent of the American foulbrood disease of honeybees. However, the inhibitory mechanism is largely unknown. Antibacterial assay and membrane proteome were conducted to investigate the inhibition capacity of RJ from different instar larvae and P. larvae treated by N-MRJP2, respectively. The similar antibacterial efficiency of RJ from different larval instar indicates that RJ is vital for the adaptive immune defense of small larvae. The killing of P. larvae by N-MRJP2 is achieved by disturbing the cell wall biosynthesis, increasing the permeability of cell membrane, hindering aerobic respiration, restraining cell division and inducing cell death. This demonstrates that RJ is critical for the passive immunity of immature larvae and N-MRJP2 can be used as natural antibiotic substance to resist P. larvae, even for other gram-positive bacteria. This constitutes solid evidence that RJ and N-MRJP2 have potentials as novel antibacterial agents.
Insights
Royal jelly (RJ) and its protein N-MRJP2 exhibit potent antibacterial activity against Paenibacillus larvae, the cause of American foulbrood. N-MRJP2 disrupts bacterial cell walls, membranes, and respiration, offering potential as a natural antibiotic.
Area of Science:
- Apiculture and Bee Health
- Microbiology
- Biochemistry
Background:
- Royal jelly (RJ), a honeybee secretion, possesses broad-spectrum antibacterial properties.
- N-glycosylated major royal jelly protein 2 (N-MRJP2) isolated from RJ inhibits Paenibacillus larvae (P. larvae), the pathogen responsible for American foulbrood disease in honeybees.
- The precise mechanism by which N-MRJP2 exerts its antibacterial effects remains largely unelucidated.
Purpose of the Study:
- To investigate the antibacterial efficacy of RJ from various larval instars.
- To elucidate the mechanism of N-MRJP2-mediated inhibition of P. larvae growth.
- To explore the potential of RJ and N-MRJP2 as natural antibacterial agents.
Main Methods:
- Antibacterial assays were performed using RJ from different honeybee larval instars.
- Membrane proteomic analysis was conducted on P. larvae treated with purified N-MRJP2.
- Comparative analysis of RJ efficacy across larval stages and detailed mechanistic studies of N-MRJP2 action.
Main Results:
- RJ demonstrated consistent antibacterial efficiency across different larval instars, highlighting its role in larval adaptive immunity.
- N-MRJP2 was found to inhibit P. larvae by disrupting cell wall biosynthesis, increasing cell membrane permeability, impairing aerobic respiration, and inhibiting cell division.
- Treatment with N-MRJP2 induced cell death in P. larvae.
Conclusions:
- Royal jelly is crucial for the passive immunity of immature honeybee larvae.
- N-MRJP2 acts as a natural antibiotic by targeting multiple essential cellular processes in P. larvae.
- Both RJ and N-MRJP2 show significant potential as novel antibacterial agents against P. larvae and other Gram-positive bacteria.
More Related Videos
Related Concept Videos
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Gram-negative Bacterial Protein Secretion Systems
Gene Regulation in Microbial Communities: Quorum Sensing
Bacterial Cell Wall
Coordination of Gene Expression Processes in Bacteria

